Strategic Advances in Avian Influenza Vaccines: Key Contributions from QYH Biotech and Ceva in H5, H7, and H9 Protection
The Avian Influenza Vaccine market is anticipated to reach USD 1.18 Billion 2032 at a CAGR 7.5% during the forecast period 2023-2032.
The Avian Influenza Vaccine Market is witnessing robust growth due to heightened awareness of avian influenza outbreaks globally. With the threat of avian flu strains like H5N1 and H7N9, the market for avian influenza vaccines has expanded significantly. Rising...
0 Reacties
0 aandelen
32 Views
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek